Clinical Trial Update: The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating dalteparin for treating deep vein thrombosis in cancer patients and its effect on central venous catheter survival.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Venous Thromboembolism

Drugs mentioned

• Dalteparin (dalteparin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Embolism and Thrombosis | Phase 2 | Status: COMPLETED